Last Updated: November 8, 2026

CEPHALEXIN - Generic Drug Details

« Back to Dashboard


What are the generic sources for cephalexin and what is the scope of patent protection?

Cephalexin is the generic ingredient in five branded drugs marketed by Ajenat Pharms, Alkem Labs Ltd, Anda Repository, Apothecon, Aurobindo Pharma, Barr, Chartwell Rx, Facta Farma, Hikma, Ivax Sub Teva Pharms, Lupin, Purepac Pharm, Stevens J, Sun Pharm Inds (in), Sun Pharm Inds Ltd, Teva, Yoshitomi, Pragma, Hikma Pharms, Vitarine, Yung Shin Pharm, Ranbaxy Labs Ltd, Aurobindo Pharma Ltd, and Lilly, and is included in fifty-eight NDAs. Additional information is available in the individual branded drug profile pages.

Thirty-five suppliers are listed for this compound.

Summary for CEPHALEXIN
Drug Prices for CEPHALEXIN

See drug prices for CEPHALEXIN

Drug Sales Revenue Trends for CEPHALEXIN

See drug sales revenues for CEPHALEXIN

Recent Clinical Trials for CEPHALEXIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Turku University HospitalPHASE1
University of TurkuPHASE1
Helsinki University Central HospitalPHASE1

See all CEPHALEXIN clinical trials

Pharmacology for CEPHALEXIN
Medical Subject Heading (MeSH) Categories for CEPHALEXIN

US Patents and Regulatory Information for CEPHALEXIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma CEPHALEXIN cephalexin FOR SUSPENSION;ORAL 213568-001 Jun 9, 2026 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Vitarine CEPHALEXIN cephalexin TABLET;ORAL 062863-002 Aug 11, 1988 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Ivax Sub Teva Pharms CEPHALEXIN cephalexin CAPSULE;ORAL 061969-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Chartwell Rx CEPHALEXIN cephalexin CAPSULE;ORAL 065152-001 Feb 24, 2005 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Teva CEPHALEXIN cephalexin TABLET;ORAL 063024-002 Jan 12, 1989 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Pragma KEFLEX cephalexin CAPSULE;ORAL 050405-004 May 12, 2006 DISCN Yes No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Lilly KEFLET cephalexin TABLET;ORAL 062745-002 Dec 1, 1986 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.